{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-034689","form_type":"8-K","ticker":"GRDX","cik":"0001604191","company_name":"GridAI Technologies Corp.","filed_at":"2025-04-14T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.981519+00:00","generated_at":"2026-05-23T15:28:08.827972+00:00","sec_items":["3.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.85,"confidence":"high","headline":"Entero Therapeutics receives Nasdaq deficiency notice for stockholders' equity shortfall","bullets":["Stockholders' equity of ($3,876,738) as of Dec 31, 2024, well below Nasdaq's $2.5M minimum.","Company also failed alternative compliance standards for market value or net income.","Must submit compliance plan by May 26, 2025; Nasdaq may grant extension to Oct 8, 2025.","Company intends to submit a plan, but no assurance of acceptance or regaining compliance."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-034689","json":"https://secwatch.observer/filing/0001104659-25-034689.json","markdown":"https://secwatch.observer/filing/0001104659-25-034689.md","text":"https://secwatch.observer/filing/0001104659-25-034689.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1604191/000110465925034689/0001104659-25-034689-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1604191/000110465925034689/tm2512284d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T15:28:08.827972+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}